New class of inhibitor may attack resistance. Potential drug could be cost-efficient.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

New class of inhibitor may attack resistance. Potential drug could be cost-efficient.

AIDS alert - 1 Jan 2005

Abstract excerpt

There is new hope for a cost-efficient treatment for HIV-1 infected patients who no longer respond to protease inhibitor (PI) treatment due to multidrug resistance.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Drug Resistance, Viral
Share to HIV Infections
Share to HIV Protease Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Source

Open in PubMed

Identifiers

PMID: 15717354

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

New class of inhibitor may attack resistance. Potential drug could be cost-efficient.PMID 15717354Read ↗

Clinical Utility of Current NNRTIs and Perspectives of New Agents in This Class under DevelopmentSemantic proximity Read ↗

Mechanisms of anti-retroviral drug resistance: implications for novel drug discovery and development.Semantic proximity Read ↗

HIV resistance: the new enemy.Semantic proximity Read ↗

Discovering new biology with drug-resistance alleles.Semantic proximity Read ↗

“Old Dogs with New Tricks”: exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targetsSemantic proximity Read ↗

The importance of bio-computational tools for predicting HIV drug resistance.Semantic proximity Read ↗

[Resistance to protease inhibitors].Semantic proximity Read ↗

New strategies to combat HIV drug resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.